Mechanistically, high-CIP2A levels in primary CML correlate with high levels of S62-phosphorylated c-Myc (129) and increased resistance to bortezomib-induced apoptosis (131). This evidence concerns the gene CIP2A and chronic myelogenous leukemia, BCR-ABL1 positive.